Authors:
Watanabe, R
Wada, H
Miura, Y
Murata, Y
Watanabe, Y
Sakakura, M
Okugawa, Y
Nakasaki, T
Mori, Y
Nishikawa, M
Gabazza, EC
Shiku, H
Nobori, T
Citation: R. Watanabe et al., Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura, CL APPL T-H, 7(3), 2001, pp. 229-233
Authors:
Mori, Y
Wada, H
Okugawa, Y
Tamaki, S
Nakasaki, T
Watanabe, R
Gabazza, EC
Nishikawa, M
Minami, N
Shiku, H
Citation: Y. Mori et al., Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, CL APPL T-H, 7(1), 2001, pp. 5-9
Authors:
Watanabe, R
Wada, H
Watanabe, Y
Sakakura, M
Nakasaki, T
Mori, Y
Nishikawa, M
Gabazza, EC
Nobori, T
Shiku, H
Citation: R. Watanabe et al., Activity and antigen levels of thrombin-activatable fibrinolysis inhibitorin plasma of patients with disseminated intravascular coagulation, THROMB RES, 104(1), 2001, pp. 1-6
Authors:
Sakakura, M
Wada, H
Watanabe, R
Mamamuro, M
Okugawa, Y
Nakasaki, T
Nakase, T
Wakita, Y
Minamikawa, K
Mori, Y
Nshikawa, M
Shiku, H
Citation: M. Sakakura et al., Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant, CL APPL T-H, 6(3), 2000, pp. 144-150
Authors:
Inoue, A
Wada, H
Takagi, M
Yamamuro, M
Mukai, K
Nakasaki, T
Shimura, M
Hiyoyama, K
Deguchi, H
Gabazza, EC
Mori, Y
Nishikawa, M
Deguchi, K
Shiku, H
Citation: A. Inoue et al., Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis, CL APPL T-H, 6(2), 2000, pp. 100-103
Authors:
Okugawa, Y
Wada, H
Noda, T
Sakakura, M
Nakasaki, T
Watanabe, R
Deguchi, H
Gabazza, EC
Mori, Y
Nishikawa, M
Deguchi, K
Nobori, T
Shiku, H
Citation: Y. Okugawa et al., Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation, AM J HEMAT, 65(3), 2000, pp. 210-214
Authors:
Watanabe, R
Wada, H
Sakakura, M
Mori, Y
Nakasaki, T
Okugawa, Y
Gabazza, EC
Hayashi, T
Nishioka, J
Suzuki, K
Shiku, H
Nobori, T
Citation: R. Watanabe et al., Plasma levels of activated protein C protein C inhibitor complex in patients with hypercoagulable states, AM J HEMAT, 65(1), 2000, pp. 35-40
Authors:
Nakasaki, T
Wada, H
Mori, Y
Okugawa, Y
Watanabe, R
Nishikawa, M
Gabazza, EC
Masuya, M
Kageyama, S
Kumeda, K
Kato, H
Shiku, H
Citation: T. Nakasaki et al., Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia, AM J HEMAT, 64(3), 2000, pp. 145-150
Authors:
Ikuma, H
Wada, H
Mori, Y
Shimura, M
Hiyoyama, K
Nakasaki, T
Nishikawa, M
Onoda, K
Yamada, N
Ohta, T
Nishioka, J
Nobori, T
Gabazza, EC
Sakuragawa, N
Shiku, H
Citation: H. Ikuma et al., Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring, BL COAG FIB, 10(7), 1999, pp. 429-434
Authors:
Hori, Y
Wada, H
Mori, Y
Shimura, M
Hiyoyama, K
Nakasaki, T
Nishii, K
Tamaki, S
Nishikawa, M
Deguchi, K
Minami, N
Shiku, H
Citation: Y. Hori et al., Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation, AM J HEMAT, 61(1), 1999, pp. 21-25
Authors:
Wada, H
Sakuragawa, N
Mori, Y
Takagi, M
Nakasaki, T
Shimura, M
Hiyoyama, K
Nisikawa, M
Gabazza, EC
Deguchi, K
Kazama, M
Shiku, H
Citation: H. Wada et al., Hemostatic molecular markers before the onset of disseminated intravascular coagulation, AM J HEMAT, 60(4), 1999, pp. 273-278
Authors:
Shimura, M
Wada, H
Nakasaki, T
Hiyoyama, K
Mori, Y
Nishikawa, M
Deguchi, H
Deguchi, K
Gabazza, EC
Shiku, H
Citation: M. Shimura et al., Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation, AM J HEMAT, 60(2), 1999, pp. 94-98